Sanford Church, M.D. Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1500 Duarte Rd, Duarte, CA 91010 Phone: 626-256-4673 |
Dr. Hugh Cole Davis, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1500 Duarte Rd, Duarte, CA 91010 Phone: 626-256-4673 |
Aria Hong, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1500 Duarte Rd, Duarte, CA 91010 Phone: 626-256-4673 |
Ms. Anna Kim, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1500 E Duarte Rd, Duarte, CA 91010 Phone: 626-359-8111 |
Dr. Argelia Sandoval, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1500 E Duarte Rd, Duarte, CA 91010 Phone: 626-359-8111 |
Mr. David Horak, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1500 E Duarte Rd, Duarte, CA 91010 Phone: 626-359-8111 |
News Archive
ABIVAX, a clinical stage biotech company developing and commercialising anti-viral compounds and human vaccines, today announced that it has dosed in New Zealand the first patient in a Phase IIb/III clinical trial of ABX203 which is taking place in several countries of the Asia-Pacific region.
Patrys Limited, a clinical stage biotechnology company is pleased to announce the publication of a new scientific article regarding its product PAT-SC1 in the Oncology Reports journal. The article is currently available online and will be included in a future print edition of the journal.
Peregrine Pharmaceuticals today announced that there will be two presentations, April 4 and 6, at the American Association of Immunologists (AAI) annual meeting in San Diego, California, indicating the anti-viral potential of its Tarvacin antibody. Dr. Melina Soares of The University of Texas Southwestern Medical Center at Dallas will present pre-clinical data titled "Targeting inside-out phospholipids on viruses in a guinea pig model of Lassa fever."
Johns Hopkins scientists have decoded for the first time the "stability blueprint" of an enzyme that resides in a cell's membrane, mapping which parts of the enzyme are important for its shape and function.
› Verified 9 days ago